The Investor
02 Sep 2026, 15:55
InterContinental Hotels Group Stock Rises 3.7% as UBS Upgrades Shares to Buy
InterContinental Hotels Group (NYSE: IHG) shares rose about 3.7% Wednesday after UBS upgraded the hotel operator to Buy from Neutral and set a $188 price target.
IHG shares were trading around $161.04, meaning UBS’s $188 target implies approximately 17% upside from the current share price.
InterContinental Hotels Group is one of the world’s largest hotel companies, with brands including Holiday Inn, Holiday Inn Express, InterContinental, Crowne Plaza and Hotel Indigo. Its predominantly asset-light franchise and management model gives the company broad exposure to global travel demand while limiting direct ownership of hotel real estate.
The upgrade provides a fresh positive catalyst for IHG shares. The rating information shown does not provide UBS’s detailed reasoning, but the move from Neutral to Buy represents a clear improvement in the firm’s view of the stock.
IHG’s 3.7% gain appears to reflect favorable investor reaction to the upgrade, with UBS’s $188 target suggesting additional upside despite Wednesday’s advance.
InterContinental Hotels Group (NYSE: IHG) shares rose about 3.7% Wednesday after UBS upgraded the hotel operator to Buy from Neutral and set a $188 price target.
IHG shares were trading around $161.04, meaning UBS’s $188 target implies approximately 17% upside from the current share price.
InterContinental Hotels Group is one of the world’s largest hotel companies, with brands including Holiday Inn, Holiday Inn Express, InterContinental, Crowne Plaza and Hotel Indigo. Its predominantly asset-light franchise and management model gives the company broad exposure to global travel demand while limiting direct ownership of hotel real estate.
The upgrade provides a fresh positive catalyst for IHG shares. The rating information shown does not provide UBS’s detailed reasoning, but the move from Neutral to Buy represents a clear improvement in the firm’s view of the stock.
IHG’s 3.7% gain appears to reflect favorable investor reaction to the upgrade, with UBS’s $188 target suggesting additional upside despite Wednesday’s advance.
